Jefferies Updates Elevance Health, Inc. (ELV) Forecasts After Deeper Analysis of Exchange Segment Dynamics

We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. Elevance Health, Inc. is one of the most undervalued stocks on this list.

TheFly reported on April 20 that Jefferies analyst David Windley revised his outlook on ELV, trimming the firm’s price target to $391 from $395 while maintaining a Buy rating on the stock. The adjustment follows a detailed evaluation of health insurance offerings within the Health Insurance Exchange market. Based on this deeper analysis, the firm updated its financial projections across its managed care coverage, reflecting refined assumptions tied to plan dynamics and market conditions in the exchange segment.

Separately, earlier on March 31, Elevance Health, Inc. (NYSE:ELV) announced a set of senior leadership changes spanning its Health Benefits segment and Carelon services division to support operational execution and long-term growth. The restructuring is intended to improve coordination across business units, enhance efficiency, and accelerate decision-making as the company expands its services platform.

Jefferies Updates Elevance Health, Inc. (ELV) Forecasts After Deeper Analysis of Exchange Segment Dynamics

Carelon, which delivers healthcare, pharmacy, behavioral, and data-driven solutions to a large consumer base, remains a key focus of this strategy. The updated leadership structure also aims to strengthen integration with the Health Benefits business, enabling more aligned offerings that improve care outcomes, reduce costs, and simplify the overall healthcare experience for members while supporting sustained enterprise performance.

Elevance Health, Inc. (NYSE:ELV) is a U.S. health company providing managed care and health solutions to over 119 million people. It operates across commercial, Medicare, and Medicaid markets through brands like Anthem Blue Cross Blue Shield, WellPoint, and Carelon.

While we acknowledge the risk and potential of ELV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ELV and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 AI-Powered Biotech Stocks to Buy Right Now and 10 Most Undervalued Dow Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.